TORONTO, May 26, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS"
or the "Company") (TSX: HLS), a specialty pharmaceutical company
focused on central nervous system and cardiovascular markets,
announces that Gilbert Godin, CEO,
and Tim Hendrickson, CFO, will
participate in two upcoming investor conferences in the month of
June.
1. Jefferies Virtual Healthcare Conference
June 1-4, 2021
- HLS presents Tuesday June 1, 2021
at 8:30am EDT
- Listen to the live webcast, click here
2. Raymond James Human Health Innovation
Conference June 21-23, 2021
- HLS presents Wednesday June 23,
2021 at 9:20am EDT
- Listen to the webcast, click here
ABOUT HLS THERAPEUTICS INC.
Formed in 2015, HLS is a
specialty pharmaceutical company focused on the acquisition and
commercialization of late-stage development, commercial stage
promoted and established branded pharmaceutical products in the
North American markets. HLS's focus is on products targeting the
central nervous system and cardiovascular therapeutic areas. HLS's
management team is composed of seasoned pharmaceutical executives
with a strong track record of success in these therapeutic areas
and at managing products in each of these lifecycle stages. For
more information, please visit: www.hlstherapeutics.com
SOURCE HLS Therapeutics Inc.